Drawing for ROTOR-GENE

USPTO serial 79071658

ROTOR-GENE

Reviewed by CopyMark Law Group

Reg. 3872943Status 706Registered
Filing date
Status date
Registration date
Nov 9, 2010
Examiner
MORENO, PAUL A
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with ROTOR-GENE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Victoria Friedman

Victoria Friedman Dennemeyer & Associates, LLC2 North Riverside Plaza, Suite 1500Chicago, IL 60606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical and biotechnological products for industrial and scientific purposes, in particular nucleic acids, enzymes, polymerases, reagents for staining and marking, molecular probes, buffer, aqueous and non-aqueous solutions of alcohols and salts, distilled and purified water, silica in powdered, granulate and gel form and magnetic particles in fluid form, none of the foregoing for medical or veterinary purposes; [ materials for reaction vessels and reagents and solvents for sample preparation, all of the foregoing for the purpose of purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; ] kits comprising chemical, biochemical and biotechnological products for [ sample preparation, purification, lysis, modification and manipulation of cells as well as for ] the performance of [ marking, separation, isolation, purification, ] amplification and analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, in particular nucleic acids made from biological and biochemical sample material, none of the foregoing for medical or veterinary purposesACTIVE—
005[ Products for medical and veterinary medical purposes, in particular diagnostic preparations, in particular nucleic acids, enzymes, polymerases, reagents for staining and marking, molecular probes, buffer chemicals and aqueous and non-aqueous solutions of primary, secondary and tertiary alcohols and salts, distilled and purified water, magnetic particles in fluid form, and materials for reaction vessels for the purpose of purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, all of the foregoing for medical and veterinary purposes; products for medical and veterinary medical purposes, namely, chemical, biochemical and biotechnological products as well as kits comprising products for medical and veterinary medical purposes, in particular chemical, biochemical and biotechnological products for sample preparation, purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids for medical and veterinary medical purposes, enzymes, natural and artificial proteins, macro molecules, and biologically active substances for detecting pathogens, genetic information and conditions of the human body ]SECTION 71 - CANCELLED—
009Scientific apparatus, instruments and equipment for scientific research, non-medical diagnostic analysis, chemical analysis, clinical analysis and industrial use, namely, DNA and RNA testing apparatus, namely, [ sequencers, genetic analyzers, ]polymerase chain reaction (PCR) cyclers, thermocyclers, [ vacuum concentrators, ] high resolution melt analysis machines, [ electroporators, pipetting equipment, incubators, rotary chemical analyzers, namely, laboratory centrifuges, thermo-optical gas analyzers, thermo-optical carbon analyzers; rotary chemical and thermo-optical analyzer parts and accessories, namely, microplates, disc-based rotary plates, reaction tubes, locking rings, loading blocks, pipetting aids, namely, dispensers for laboratory use, burettes, laboratory racks and holders for sample storage vessels, syringes, heat sealers and heat sealing film; biomolecular screening adaptors; laboratory equipment, namely, microplates, pipettes, pipette tips, pipette tip holders, sample containers, namely, tubes for PCR and laboratory centrifuges, test tubes, sample tubes, tube strips, plates, vials, petri dishes holders for sample containers, namely, laboratory racks, assay trays, pipette racks; ] computer software for operation and maintenance of scientific apparatus, instruments and equipment; computer software for creating experimental profiles, providing experimental reports and reports of apparatus performance verificationACTIVE—
010Apparatus for medical and veterinary diagnostic analysis and determination of medical and veterinary conditions, namely, DNA and RNA testing apparatus and thermo-optical analysersACTIVE—
042[ Scientific research for others in the fields of chemistry, genetics, biology and biochemistry; scientific diagnostic services for others in the fields of DNA, RNA and protein detection and analysis; scientific and research services for others utilising rotary chemical and thermo-optical analysers; research services in the field of forensic science, namely, analysis, detection and isolation of biological substances in forensic samples ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 30, 2021INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Sep 14, 2021INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 14, 2021NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 14, 202171AGREGISTERED-SEC.71 ACCEPTED—
Jan 14, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 12, 2020ES71TEAS SECTION 71 RECEIVED—
Nov 9, 2019REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Apr 11, 2019RNWLINTERNATIONAL REGISTRATION RENEWED—
Jan 11, 2018INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Dec 6, 2017INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Dec 6, 2017INPCINVALIDATION PROCESSED—
Nov 27, 2017INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 27, 2017NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Mar 27, 2017C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Mar 24, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 10, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 9, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 16, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 11, 2016ES75TEAS SECTION 71 & 15 RECEIVED—
Feb 18, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 17, 2011FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 17, 2011FIMPFINAL DISPOSITION PROCESSED—
Feb 9, 2011FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 27, 2010CHLDCHANGE OF OWNER RECEIVED FROM IB—
Nov 9, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 24, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 24, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 21, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 21, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 21, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Jul 21, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 21, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 21, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 28, 2010GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 28, 2010GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 28, 2010CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 1, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 1, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 1, 2010ALIEASSIGNED TO LIE—
Mar 24, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 24, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 16, 2009RFNTREFUSAL PROCESSED BY IB—
Sep 25, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 25, 2009RFRRREFUSAL PROCESSED BY MPU—
Sep 25, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 24, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 15, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 11, 2009DOCKASSIGNED TO EXAMINER—
Sep 11, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 10, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance